Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Update San Marino.
Press releases published on August 28, 2025

Merus to Present at the 2025 Wells Fargo Healthcare Conference
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics®, Triclonics® and ADClonics …

ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves from allergic reactions that could lead to …

Crescent Biopharma to Present at September Investor Conferences
WALTHAM, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management …

Xtract One Selected by Temple University to Fortify Security at The Liacouras Center
TORONTO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway system has been selected by Temple University (“Temple”), located in Philadelphia, PA, …

Kura Oncology to Participate in Three Upcoming Investor Conferences
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that management is scheduled …

Ollie’s Bargain Outlet Holdings, Inc. Announces Second Quarter Fiscal 2025 Results
Store Openings, Sales, and Earnings Ahead of Expectations Net Sales Increased 17.5% and Earnings Per Share Increased 25.0% Raising Fiscal 2025 Sales and Earnings Outlook HARRISBURG, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Ollie’s Bargain Outlet Holdings, …

Palvella Therapeutics to Present at Upcoming Healthcare Investor Conferences
WAYNE, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic …

Stock Yards Bancorp to Participate in the Raymond James 2025 U.S. Bank and Banking on Tech Conferences
LOUISVILLE, Ky., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank …

Zevra Therapeutics Announces Multiple Datasets on MIPLYFFA® (arimoclomol) to be Presented at the International Congress of Inborn Errors of Metabolism (ICIEM)
CELEBRATION, Fla., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced four posters on MIPLYFFA® …

Draganfly Announces Expansion of U.S. Manufacturing Footprint and Capacity to Meet Demand for Scalable U.S.-Made Drone Solutions
Tampa, Florida, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an industry-leading developer of drone solutions and systems, is pleased to announce the expansion of its U.S. …

Caliber Establishes LINK Token Digital Asset Treasury
Strategy Merges Digital and Real World Assets, Investing in the Infrastructure Layer of Blockchain Technology Positions Caliber as a First-mover Among U.S. Public Companies in the Adoption of Blockchain-based Treasury Management Practices Focused on LINK …

Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
MIAMI, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, today announced management will …

Bitcoin Swift Presale Enters Final Hours as Early Launch Confirmed for August 30
LUXEMBOURG, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Bitcoin Swift (BTC3) has announced that its highly anticipated presale is entering the final hours, with more than $1.3 million raised and over 5,500 users registered. The project confirmed an early launch …

EDAP Reports Strong Second Quarter 2025 HIFU Results
+140% Focal One® Net Placement Growth Year over Year +76.8% HIFU Revenue Growth Year over Year 36 million Euro Credit Facility Letter of Intent Executed with European Investment Bank (EIB) to further accelerate HIFU Growth and Strategic Expansion Company …

Akero Therapeutics to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …

Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
CHAPEL HILL, N.C., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, …

Greenbacker delivers second quarter results
Company executes strategic non-core asset sales, flagship project progress, and proactive project management to further strengthen financial position for long-term growth and profitability Key Takeaways Greenbacker advanced commitment to scaled clean …

AAVantgarde to Present Updated Clinical Data from LUCE-1 Study at EURetina 2025
MILAN, Aug. 28, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced the presentation of updated LUCE-1 clinical data at the …

Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference
PHILADELPHIA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that management will participate in the …

Whitestone REIT Declares Fourth Quarter 2025 Dividend
HOUSTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced that its Board of Trustees has declared a monthly cash dividend of $0.045 per share on the Company's common shares and operating …